Heliyon (Jan 2024)

The clinical utilization of SNIP1 and its pathophysiological mechanisms in disease

  • Yinzhong Chen,
  • Wei Guo,
  • Xiucheng Guo,
  • Qiao Wanqing,
  • Zongsheng Yin

Journal volume & issue
Vol. 10, no. 2
p. e24601

Abstract

Read online

Smad intranuclear binding protein 1 (SNIP1), a highly conserved nuclear protein, functions as a transcriptional regulator and exerts a significant influence on disease progression. In addition, the N-terminal domain of SNIP1 facilitates its interaction with Smad4, a signaling protein associated with the TGF-β family, and RelA/p65, a transcription factor connected to NF-κB. This interaction further enhances the transcriptional activation of c-Myc-dependent genes. Presently, the primary emphasis in research is directed towards targeting the catalytic domain of SNIP1, as it holds promise as a potential therapeutic target for various diseases. While the significance of SNIP1 in pathological mechanisms remains uncertain, this review aims to comprehensively examine the existing literature on the association between SNIP1 and proteins implicated in the regulation of diverse clinical conditions, including cancer, inflammation, and related diseases.

Keywords